Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
162
-
Total 13F shares, excl. options
-
5.98M
-
Shares change
-
+371K
-
Total reported value, excl. options
-
$397M
-
Value change
-
+$26.7M
-
Put/Call ratio
-
1.1
-
Number of buys
-
106
-
Number of sells
-
-46
-
Price
-
$66.35
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q3 2016
191 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q3 2016.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 162 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.98M shares
of 22.3M outstanding shares and own 26.82% of the company stock.
Largest 10 shareholders include BlackRock Fund Advisors (719K shares), Consonance Capital Management LP (653K shares), VANGUARD GROUP INC (389K shares), STATE STREET CORP (339K shares), NOMURA HOLDINGS INC (206K shares), Healthcare Value Capital, LLC (200K shares), Bank of New York Mellon Corp (194K shares), BlackRock Institutional Trust Company, N.A. (192K shares), RENAISSANCE TECHNOLOGIES LLC (191K shares), and Fiera Capital Corp (184K shares).
This table shows the top 162 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.